Educational content series — neutral, no vendor promotion. Written without em dashes. Mescaline and the Cactus Traditions: San Pedro, Peyote, and the Long Walk The Forgotten Classic In the modern psychedelic conversation, mescaline is the quiet third member of the classical trio. Psilocybin has the clinical trials and the ballot measures. LSD has the history […]
Category Archives: Uncategorized
Five Minutes, Eternity, and a White Amphibian If the DMT story has a strange cousin, it is this. 5-methoxy-DMT is a close molecular relative of the DMT covered in this series, differing by a single methoxy group, and the difference is the widest experiential gulf in the entire psychedelic pharmacopeia. Where N,N-DMT delivers the geometric […]
Where the Science Is Strongest and the Marketing Is Loudest Epilepsy is the one domain of cannabis medicine where the evidence achieved the highest standard the modern system offers: an FDA approval. Epidiolex, a purified oral CBD, won approval in 2018 for two catastrophic pediatric epilepsy syndromes, Dravet syndrome and Lennox-Gastaut syndrome, on the strength […]
The Most Politically Complicated Use Case No area of cannabis medicine carries more emotional weight, more ethical complexity, or less rigorous evidence than its use in autism. The parent communities are large, organized, and vocal: families of children with severe autism, particularly those with self-injurious behaviors, profound irritability, and sleep disruption that resist every available […]
The Most Common Undiscussed Overlap Attention-deficit/hyperactivity disorder and cannabis have a large, quiet, and poorly understood overlap. Adults with ADHD use cannabis at rates substantially above the general population in every survey; a large fraction of regular adult cannabis users meet screening criteria for undiagnosed ADHD; and the most common explanation offered from inside the […]
The Experiment Everyone Cites, Few Have Read Portugal's 2001 decriminalization of all drugs, every substance, in every amount for personal use, replaced criminal penalties with administrative offenses handled by dissuasion commissions, while maintaining criminal penalties for trafficking and expanding treatment access, is the most cited natural experiment in drug policy and the least accurately summarized. […]
The Policy the World Watched The Netherlands has run history's longest-running experiment in drug-policy pragmatism. For over forty years, the Dutch system has combined formal prohibition with practical tolerance: the famous coffeeshops selling cannabis openly under regulated conditions, the "gedoogbeleid" (toleration policy) that decriminalized personal possession of small amounts of all drugs, a harm-reduction infrastructure […]
Where the Plants Come From, Finally Deciding The psychedelic renaissance's deepest geographic irony is that its center of gravity, clinical trials, venture capital, licensed frameworks, ballot measures, sits almost entirely in the Global North, while the plants at the renaissance's foundation come almost entirely from the Global South, from Amazonian ayahuasca lineages, Andean San Pedro […]
When the State Itself Became the Harm Every entry in this series' drug-policy coverage has treated prohibition's harms as structural: the black markets, the contamination, the incarceration, the violence that follows the illegal economy's logic. The Philippines under Rodrigo Duterte (2016 to 2022) added a dimension that policy analysis rarely has to confront directly: the […]
Where the Trajectories Point This series has covered a hundred years of pharmacology and policy: the first golden age and the blackout, the drug war's construction and its partial dismantling, the fentanyl catastrophe and the harm reduction response, the psychedelic renaissance and its gold rush. The natural closing question is the forward one: where does […]
